Connect with us below to support shifting the paradigm:
Did you know that in the US, nearly 90% of pregnant women take at least one medication, yet fewer than 1% of clinical drug trials include pregnant participants?
Watch the recording for a timely discussion with VOZ Advisors and BRIDGE (Better Research, Information and Data Generation for Empowerment) on the lack of data on chronic disease treatment during pregnancy and breastfeeding, the value of inclusive research, and the role of patient advocates in shifting the paradigm from protecting women from research to protecting women through research.
A conversation with:
Professor of Social Medicine at the University of North Carolina at Chapel Hill, BRIDGE Member
Read Anne’s full bio here.
Patient & Public Involvement in Women’s Health Research Leader; Honorary Research Fellow at Queen Mary University of London; Founding Member of Elly Charity, BRIDGE Co-Chair
Read Ngawai’s full bio here.
Former Clinical Advisor at FDA; Developmental Toxicology, BRIDGE Co-Chair
Read Melissa’s full bio here.
Head of Women of Childbearing Age Mission, UCB, BRIDGE Co-Chair
Read Marie’s full bio here.
Connect with us below to support shifting the paradigm:
Related resources shared during live webinar:
- To learn more about BRIDGE, please visit: https://www.bridgeforwocba.org/
- To learn more about the first-ever Medicines and Healthcare products Regulatory Agency (MHRA) analysis of United Kingdom (UK) clinical trial applications, please visit: https://www.gov.uk/government/news/first-ever-mhra-analysis-of-uk-clinical-trial-applications-finds-new-opportunities-to-drive-medical-breakthroughs-for-patients
- To read BRIDGE’s report about Closing the Data Gap, please visit: https://www.bridgeforwocba.org/recommendations-report
- To learn more about the International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) E21 guideline on inclusion of pregnant and breastfeeding individuals in clinical trials: https://www.ema.europa.eu/en/ich-e21-guideline-inclusion-pregnant-breastfeeding-individuals-clinical-trials-scientific-guideline
- To learn more about the ICH E21 draft guideline: https://www.fda.gov/media/187755/download
About VOZ Advisors: VOZ Advisors is a global consulting company focused exclusively on patient advocacy and engagement. Our focus is on helping biopharmaceutical companies engage meaningfully with the communities they hope to serve with their products.
About BRIDGE: BRIDGE (Better Research, Information and Data Generation for Empowerment) is an independent, multidisciplinary group committed to the advancement of practical and action-oriented solutions to overcome information gaps that affect women’s health before, during, and after pregnancy. Read BRIDGE’s recommendations report, Closing the Information Gap: Chronic Disease, Pregnancy, and Breastfeeding